Matrine containing composition for treatment or prevention of mammal cancer and other diseases
A mammalian and matrine-based technology, which is applied in drug combinations, allergic diseases, respiratory diseases, etc., can solve the problems of difficult selection of irradiation dose, short maintenance time, and high price
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Embodiment 1: A composition for cancer prevention and treatment, the composition includes matrine, bilberry extract, ginsenoside, α-linolenic acid, green tea extract, solanesol, coenzyme Q10, Hedyotis diffusa . The content of each component by mass percentage is: matrine-40%, bilberry extract-5%, ginsenoside-5%, α-linolenic acid-5%, green tea extract-5%, solanesol- 5%, Coenzyme Q10-5%, Hedyotis diffusa 30%. The case where the composition is used for the prevention and treatment of gastric cancer is as follows:
[0040] Basic information of the patient: Name: Wang xx, male, 55 years old, from Taicang City, Jiangsu Province.
[0041] Condition introduction: First visit in August 2012. Helicobacter pylori breath test +++ a few months ago (no improvement after treatment with western medicine), scanning gastroscopy showed gastric hernia on the lesser curvature of the pylorus. His father died prematurely of stomach cancer. I usually have stomach discomfort, and I am usua...
Embodiment 2
[0044] Embodiment 2: A composition for treating asthma, the composition includes matrine, black soybean hull extract, coenzyme Q10, solanesol, the content of each component is by mass percentage: matrine 40%, black soybean hull Extract 20%, Coenzyme Q10 15%, Solanesol 25%. The composition is used for the treatment of asthma, the case is as follows:
[0045] Basic information of the patient: Name: Gu xx, male, 12 years old, from Suzhou City, Jiangsu Province.
[0046] Condition introduction: I suffered from asthma since I was a child, and now I have attacks almost every month, and I am hospitalized several times a year. Simultaneously with recurrent respiratory tract infection. In June 2011, he began to use matrine-based composition therapy, and stopped after a total of 6 months of treatment. In the two and a half years since the start of treatment, the child has never had another asthma attack, nor has he been hospitalized again. Occasional upper respiratory tract infectio...
Embodiment 3
[0049]Embodiment 3: A composition with anti-heart failure effect, the composition includes matrine, black soybean hull extract, coenzyme Q10, solanesol, the content of each component is: matrine 65% , black soybean hull extract 8%, coenzyme Q10 10%, solanesol 17%. The composition can be used for the treatment of heart failure. The case is as follows:
[0050] Basic information of the patient: Name: Pan xx, male, 86 years old, from Nanjing City, Jiangsu Province.
[0051] Condition introduction: On February 20, 2012, due to repeated chest tightness, asthma, chest pain, and exacerbated by activities for two years, the local hospital diagnosed "coronary heart disease, atrial fibrillation, heart failure, left lower lung infection" and was hospitalized. Coronary dilatation, cardiotonic treatment, etc., the condition is unstable. Usually common cold and so on. At the beginning of March, the patient was discharged from the hospital on his own, and he was treated with a modified f...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com